ХРОНИЧЕСКАЯ СЕРДЕЧНАЯ НЕДОСТАТОЧНОСТЬ, ЭПИДЕМИОЛОГИЯ И РАСПРОСТРАНЕНИЕ
Ключевые слова:
хронический сердечной недостаточность, сердечно-сосудистые заболевания, факторов рискаАннотация
Хроническая сердечная недостаточность (ХСН) — это патологическое состояние, которое развивается в результате ряда генетических факторов, факторов окружающей среды и образа жизни, и в настоящее время является основной причиной инвалидности, госпитализации и смерти из-за осложнений сердечно-сосудистых заболеваний. В этой статье представлена информация о ХСН, эпидемиологии, распространенности и факторах риска.
Библиографические ссылки
Braunwald E. The war against heart failure: the Lancet lecture // Lancet. -2015, № 385(9970) – P.812–24.
GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 // Lancet.-2018, №392. – Р.1859-922.
Benjamin E.J., Muntner P., Alonso A., et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association // Circulation.-2019, №139. – Р.e56-528.
Ionescu R.F., Cretoiu S.M. MicroRNAs as monitoring markers for right-sided heart failure and congestive hepatopathy // J Med Life. -2021, №14(2). – Р.142-147.
Ponikowski P., Voors A. A., Anker S. D. et al., “2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure // European Heart Journal. -2016, №37. – Р.2129–2200.
Mentz RJ, O'Connor CM. Pathophysiology and clinical evaluation of acute heart failure. Nat Rev Cardiol. (2016) 13:28–35. doi: 10.1038/nrcardio.2015.134
Savarese G., Lund L.H. Global Public Health Burden of Heart Failure // Cardiac Failure Review. -2017, №3. – Р.7-11.
Seferovic P.M., Ponikowski P., Anker S.D. et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology // Eur J Heart Fail. -2019, №21. – Р.1169–1186.
Filippatos G., Farmakis D., Bistola V., Karavidas A., Mebazaa A., Maggioni A.P., Parissis J. Temporal trends in epidemiology, clinical presentation and management of acute heart failure: results from the Greek cohorts of the Acute Heart Failure Global Registry of Standard Treatment and the European Society of Cardiology Heart Failure pilot survey //Eur Heart J Acute Cardiovasc Care. -2014, №5. –Р.112-118.
Kurmani S., Squire I. Acute heart failure: definition, classification and epidemiology //Curr Heart Fail Rep. -2017, №14(5). – Р.385–92.
Andronic A.A., Mihaila S., Cinteza M. Heart Failure with mid-range ejection fraction – a new category of heart failure or still a gray zone //Maedica (Bucur).-2016, №11. – Р.320–324.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators, “Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 // Lancet.-2017, №390(10100). – Р.1211–1259.
GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 // Lancet. -2015, №385. – Р.117–171.
Benjamin E.J., Blaha M.J., Chiuve S.E., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2017 update: a report from the American Heart Association // Circulation.-2017, №135. – Р.146–603.
Dokainish H., Teo K., Zhu J., et al. Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study // Lancet Glob Health.-2017, №5. – Р.665-672.
MacDonald M.R., Tay W.T., Teng T.K., et al. Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN-HF Registry // J Am Heart Assoc-2020, №9. – Р.012199.
Hao G., Wang X., Chen Z., Zhang L., Zhang Y., Wei B., et al. Prevalence of heart failure and left ventricular dysfunction in China: the China hypertension survey, 2012-2015 // Eur J Heart Failure. -2019,№21. – Р.1329–37.
Gedela M., Khan M., Jonsson O. Heart Failure // S D Med. -2015,№68(9). – Р.403-405.
Waikar S.S., Mount D.B., Curhan G.C. Mortality after hospitalization with mild, moderate, and severe hyponatremia // Am J Med. -2009, №122(9). – Р.857–865.
Фомин И. В. Агеев Ф.Т. и соавт. Эпидемиология хронической сердечной недостаточности в Российской Федерации // Хроническая сердечная недостаточность. М.:ГЭОТАР-Медиа, -2010, - С. 7-77.
Lawson C.A., Zaccardi F., Squire I., et al. 20-year Trends in Cause-Specific Heart Failure Outcomes by Sex, Socioeconomic Status, and Place of Diagnosis: A Population-Based Study // Lancet Public Health.-2019, №4. – Р.406-420.
